New York State Common Retirement Fund’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.05M | Buy |
140,918
+3,000
| +2% | +$86.3K | 0.01% | 1146 |
|
2025
Q1 | $4.63M | Sell |
137,918
-17,508
| -11% | -$587K | 0.01% | 1088 |
|
2024
Q4 | $7.95M | Buy |
155,426
+7,735
| +5% | +$395K | 0.01% | 896 |
|
2024
Q3 | $7.55M | Sell |
147,691
-19,051
| -11% | -$974K | 0.01% | 922 |
|
2024
Q2 | $7.47M | Buy |
166,742
+14,250
| +9% | +$638K | 0.01% | 945 |
|
2024
Q1 | $7.14M | Buy |
152,492
+124,767
| +450% | +$5.84M | 0.01% | 962 |
|
2023
Q4 | $986K | Buy |
27,725
+44
| +0.2% | +$1.57K | ﹤0.01% | 1802 |
|
2023
Q3 | $823K | Buy |
27,681
+4,942
| +22% | +$147K | ﹤0.01% | 1844 |
|
2023
Q2 | $410K | Sell |
22,739
-6,025
| -21% | -$109K | ﹤0.01% | 2180 |
|
2023
Q1 | $462K | Sell |
28,764
-10,356
| -26% | -$166K | ﹤0.01% | 2217 |
|
2022
Q4 | $716K | Sell |
39,120
-28
| -0.1% | -$512 | ﹤0.01% | 2142 |
|
2022
Q3 | $769K | Buy |
39,148
+5,156
| +15% | +$101K | ﹤0.01% | 2098 |
|
2022
Q2 | $634K | Buy |
33,992
+2,571
| +8% | +$48K | ﹤0.01% | 2239 |
|
2022
Q1 | $690K | Buy |
31,421
+5,104
| +19% | +$112K | ﹤0.01% | 2265 |
|
2021
Q4 | $748K | Sell |
26,317
-70
| -0.3% | -$1.99K | ﹤0.01% | 2224 |
|
2021
Q3 | $555K | Sell |
26,387
-5,135
| -16% | -$108K | ﹤0.01% | 2404 |
|
2021
Q2 | $594K | Buy |
31,522
+6,722
| +27% | +$127K | ﹤0.01% | 2502 |
|
2021
Q1 | $379K | Hold |
24,800
| – | – | ﹤0.01% | 2567 |
|
2020
Q4 | $350K | Hold |
24,800
| – | – | ﹤0.01% | 2518 |
|
2020
Q3 | $389K | Hold |
24,800
| – | – | ﹤0.01% | 2336 |
|
2020
Q2 | $434K | Buy |
24,800
+12,100
| +95% | +$212K | ﹤0.01% | 2290 |
|
2020
Q1 | $187K | Hold |
12,700
| – | – | ﹤0.01% | 2490 |
|
2019
Q4 | $319K | Hold |
12,700
| – | – | ﹤0.01% | 2515 |
|
2019
Q3 | $191K | Hold |
12,700
| – | – | ﹤0.01% | 2794 |
|
2019
Q2 | $318K | Buy |
12,700
+8,600
| +210% | +$215K | ﹤0.01% | 2594 |
|
2019
Q1 | $93K | Hold |
4,100
| – | – | ﹤0.01% | 2970 |
|
2018
Q4 | $123K | Buy |
+4,100
| New | +$123K | ﹤0.01% | 2902 |
|